Effect of atenolol or metoprolol on arbutamine stress echocardiography in patients suspected of having coronary artery disease.

[1]  D. Waters,et al.  Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography. , 1997, The American journal of cardiology.

[2]  C. Dennis,et al.  Stress testing with closed-loop arbutamine as an alternative to exercise. The International Arbutamine Study Group. , 1995, Journal of the American College of Cardiology.

[3]  M. Starling,et al.  Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. The International Arbutamine Study Group. , 1995, Journal of the American College of Cardiology.

[4]  D. Bach,et al.  Clinical and diagnostic utility of arbutamine for cardiovascular stress testing during echocardiographic monitoring. , 1995, European Heart Journal.

[5]  A. Weyman,et al.  Effect of β-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography , 1995 .

[6]  K. Mullane,et al.  Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease , 1994 .

[7]  A Salustri,et al.  Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. , 1994, European heart journal.

[8]  H. Hammond,et al.  Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia. , 1994, Journal of the American College of Cardiology.

[9]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[10]  F. Pashkow,et al.  Accuracy and limitations of exercise echocardiography in a routine clinical setting. , 1992, Journal of the American College of Cardiology.